1 unchanged sentence
Exhibit Number
−Removed: Statement of Work, dated July 26, 2021, between Pilltracker Ltd.
−Removed: and NeuroRx, Inc.
+Added: Executive Employment Agreement, dated March 15, 2022, between NRx Pharmaceuticals, Inc.
+Added: and Ira Strassberg.
+Added: Consulting Agreement by and between NRx Pharmaceuticals, Inc.
+Added: and Jonathan C.
+Added: Javitt, dated as of March 8, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on March 9, 2022).
+Added: Letter Agreement by and between NeuroRx, Inc.
+Added: and REBes Consulting LLC- Robert Besthof, dated as of March 9, 2022 (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on March 9, 2022).
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
2 unchanged sentences
Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Interactive data files pursuant to Rule 405 of Regulation S-T:
−Removed: (i) Condensed Consolidated Balance Sheets as of September 30, 2021 (Unaudited) and December 31, 2020;
−Removed: (ii) Unaudited Condensed Consolidated Statements of Operations for the three months and nine months ended September 30, 2021 and 2020 ;
−Removed: (iii) Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) for the nine months ended September 30, 2021 and 2020;
−Removed: (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2021 and 2020;
+Added: Interactive data files pursuant to Rule 405 of Regulation S-T formatted in Inline XBRL:
+Added: (i) Condensed Consolidated Balance Sheets as of March 31, 2022 (Unaudited) and December 31, 2021;
+Added: (ii) Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2022 and 2021 ;
+Added: (iii) Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) for the three months ended March 31, 2022 and 2021;
+Added: (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2022 and 2021;
and (v) Notes to Unaudited Financial Statements
6 unchanged sentences
NRX PHARMACEUTICALS, INC.
−Removed: November 15, 2021
−Removed: /s/ James Brandon
+Added: /s/ Ira Strassberg
+Added: Ira Strassberg
+Added: Chief Financial Officer
+Added: (Principal Financial Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.